Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
20.65
-0.38 (-1.81%)
At close: Sep 4, 2026, 4:00 PM EDT
21.02
+0.37 (1.79%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Healthpeak Properties Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Healthpeak Properties stock has a consensus rating of "Buy" and an average price target of $23.05. The average 1-year stock price forecast is 11.62% higher than the current stock price, while the lowest is $17 (-17.68%) and the highest is $29 (+40.44%).
Price Target: $23.05 (+11.62%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Hold | 8 | 10 | 11 | 12 | 14 | 14 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 20 | 20 | 20 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $22 | Hold | Maintains | $22 | +6.54% | Sep 1, 2026 |
| Barclays | Barclays | Hold Maintains $23 → $24 | Hold | Maintains | $23 → $24 | +16.22% | Aug 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $24 → $25 | Buy | Maintains | $24 → $25 | +21.07% | Aug 24, 2026 |
| UBS | UBS | Hold Reiterates $22 | Hold | Reiterates | $22 | +4.12% | Aug 21, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $22 | Hold | Maintains | $22 | +6.54% | Aug 18, 2026 |
Financial Forecast
Revenue This Year
2.94B
from 2.82B
Increased by 4.15%
Revenue Next Year
3.15B
from 2.94B
Increased by 7.15%
EPS This Year
0.09
from 0.04
Increased by 130.77%
EPS Next Year
0.14
from 0.09
Increased by 55.56%
EPS based on non-GAAP adjusted numbers.